title: Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia.
authors.affiliation: Department of Pathology, School of Medicine, University of North Carolina, Chapel Hill 27599-7525.
authors.forename: R R
authors.initials: RR
authors.lastname: Tidwell
authors.forename: S K
authors.initials: SK
authors.lastname: Jones
authors.forename: J D
authors.initials: JD
authors.lastname: Geratz
authors.forename: K A
authors.initials: KA
authors.lastname: Ohemeng
authors.forename: C A
authors.initials: CA
authors.lastname: Bell
authors.forename: B J
authors.initials: BJ
authors.lastname: Berger
authors.forename: J E
authors.initials: JE
authors.lastname: Hall
mesh_terms: D000818:Animals; D004271:DNA, Fungal / Q000378:metabolism; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D005872:Giardia / Q000187:drug effects; D066298:In Vitro Techniques; D007894:Leishmania mexicana / Q000187:drug effects; D008297:Male; D010419:Pentamidine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D010963:Plasmodium falciparum / Q000187:drug effects; D011010:Pneumocystis / Q000187:drug effects* / Q000235:genetics; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy*; D051381:Rats; D011919:Rats, Inbred Strains; D013329:Structure-Activity Relationship
chemical_list: D004271:DNA, Fungal; D010419:Pentamidine